Auron utilizes a proprietary database of single-cell genomic data and an AI-powered computational platform to map the developmental pathways of cancer cells compared to healthy cells. This approach aims to transform malignant cells into normal functioning cells, addressing the limitations of traditional cancer therapeutics that primarily focus on cell killing.
Funding
$76.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
DBFounders
Product
Problem
Traditional cancer therapeutics primarily focus on killing malignant cells, often leading to significant side effects and the development of resistance. These approaches do not address the underlying mechanisms that drive tumorigenesis or offer a path to restoring normal cellular function.
Solution
Auron is developing a novel approach to cancer treatment that aims to transform malignant cells into healthy, functional cells. The company utilizes a proprietary database of single-cell genomic data, combined with an AI-powered computational platform, to map the developmental pathways of cancer cells and compare them to those of healthy cells. This allows for the identification of key drivers of tumorigenesis and the design of targeted therapies that can redirect cancer cells back to a normal state, rather than simply destroying them. By focusing on restoring cellular health, Auron seeks to overcome the limitations of traditional cancer treatments and offer a more effective and less toxic approach.
Target Audience
The primary target audience includes cancer patients, oncologists, and pharmaceutical companies seeking innovative and less toxic cancer treatment options.
Features
- Proprietary database of single-cell genomic data for comprehensive analysis of cancer cell states.
- AI-powered computational platform to map developmental pathways and identify drivers of tumorigenesis.
- Targeted therapies designed to redirect cancer cells back to a normal, healthy state.
- Focus on restoring cellular function rather than simply killing malignant cells.